CBD: a biomarker database for colorectal cancer

Abstract Colorectal cancer (CRC) biomarker database (CBD) was established based on 870 identified CRC biomarkers and their relevant information from 1115 original articles in PubMed published from 1986 to 2017. In this version of the CBD, CRC biomarker data were collected, sorted, displayed and analysed. The CBD with the credible contents as a powerful and time-saving tool provide more comprehensive and accurate information for further CRC biomarker research. The CBD was constructed under MySQL server. HTML, PHP and JavaScript languages have been used to implement the web interface. The Apache was selected as HTTP server. All of these web operations were implemented under the Windows system. The CBD could provide to users the multiple individual biomarker information and categorized into the biological category, source and application of biomarkers; the experiment methods, results, authors and publication resources; the research region, the average age of cohort, gender, race, the number of tumours, tumour location and stage. We only collect data from the articles with clear and credible results to prove the biomarkers are useful in the diagnosis, treatment or prognosis of CRC. The CBD can also provide a professional platform to researchers who are interested in CRC research to communicate, exchange their research ideas and further design high-quality research in CRC. They can submit their new findings to our database via the submission page and communicate with us in the CBD. Database URL: http://sysbio.suda.edu.cn/CBD/

[1]  Bharati Bapat,et al.  Epigenetic biomarkers in colorectal cancer diagnostics , 2012, Expert review of molecular diagnostics.

[2]  R. Henrik Nilsson,et al.  Finding needles in haystacks: linking scientific names, reference specimens and molecular data for Fungi , 2014, Database J. Biol. Databases Curation.

[3]  Peter B. Schiff,et al.  Surveillance Epidemiology and End Results (SEER) analysis confirms overall survival benefit with concurrent chemoradiotherapy for cervical cancer , 2013 .

[4]  Hong Zhang,et al.  Tafazzin Protein Expression Is Associated with Tumorigenesis and Radiation Response in Rectal Cancer: A Study of Swedish Clinical Trial on Preoperative Radiotherapy , 2014, PloS one.

[5]  Danny Chuon,et al.  Gastric Cancer (Biomarkers) Knowledgebase (GCBKB): A Curated and Fully Integrated Knowledgebase of Putative Biomarkers Related to Gastric Cancer , 2006, Biomarker insights.

[6]  Ahmedin Jemal,et al.  Global Cancer Incidence and Mortality Rates and Trends—An Update , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[7]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[8]  A. Jemal,et al.  Colorectal cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[9]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[10]  L. Hood,et al.  A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. , 2012, New biotechnology.

[11]  Charles Auffray,et al.  P4 medicine needs P4 education. , 2014, Current pharmaceutical design.

[12]  Bairong Shen,et al.  Knowledge-Guided Bioinformatics Model for Identifying Autism Spectrum Disorder Diagnostic MicroRNA Biomarkers , 2016, Scientific Reports.

[13]  C. Sawyers The cancer biomarker problem , 2008, Nature.

[14]  Bairong Shen,et al.  Integrative analysis reveals disease-associated genes and biomarkers for prostate cancer progression , 2014, BMC Medical Genomics.

[15]  Hong Zhang,et al.  WRAP53 is an independent prognostic factor in rectal cancer- a study of Swedish clinical trial of preoperative radiotherapy in rectal cancer patients , 2012, BMC Cancer.

[16]  David L. Wheeler,et al.  GenBank , 2015, Nucleic Acids Res..

[17]  Paula Ribeiro,et al.  miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis , 2016, Nucleic Acids Res..

[18]  L. Hood,et al.  Predictive, personalized, preventive, participatory (P4) cancer medicine , 2011, Nature Reviews Clinical Oncology.

[19]  M. Phipps,et al.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[20]  Ming Yi,et al.  bioDBnet: the biological database network , 2009, Bioinform..

[21]  Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation , 2008, Annals of Internal Medicine.

[22]  Jiajia Chen,et al.  Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network , 2016, Oncotarget.

[23]  In Seok Yang,et al.  IDBD: Infectious Disease Biomarker Database , 2007, Nucleic Acids Res..

[24]  J. Somberg,et al.  Biomarkers and surrogate endpoints. , 1999, American journal of therapeutics.

[25]  Claudia M Denkinger,et al.  A tuberculosis biomarker database: the key to novel TB diagnostics. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[26]  Damian Szklarczyk,et al.  The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible , 2016, Nucleic Acids Res..

[27]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[28]  J. Hill,et al.  Review of biomarkers in colorectal cancer , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[29]  J. Aronson Biomarkers and surrogate endpoints. , 2005, British journal of clinical pharmacology.

[30]  P. Mendola,et al.  Development of a biomarkers database for the National Children's Study. , 2005, Toxicology and applied pharmacology.

[31]  Rebecca L. Siegel Mph,et al.  Colorectal cancer statistics, 2014 , 2014 .

[32]  Mukesh Verma,et al.  Epigenetic Biomarkers in Colorectal Cancer , 2016, Molecular Diagnosis & Therapy.

[33]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[34]  Wen-Lian Hsu,et al.  LiverCancerMarkerRIF: a liver cancer biomarker interactive curation system combining text mining and expert annotations , 2014, Database J. Biol. Databases Curation.

[35]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.